AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CITALOPRAM
11 registrations across 4 African markets— 8 active
Markets with CITALOPRAM
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| O-PAM 10 TABLETS | 🇬🇭Ghana | — | active | Dec 2028 |
| O-PAM 10 TABLETS | 🇬🇭Ghana | — | active | Dec 2028 |
| ADCO-TALOMIL 40 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| CELOPRAM Solution buvable / 40 mg/ml | 🇹🇳Tunisia | ADWYA | expired | Nov 2009 |
| CELOPRAM Comprimé pelliculé sécable / 20 mg | 🇹🇳Tunisia | ADWYA | expired | May 2009 |
| ADCO-TALOMIL 10 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| ADCO TALOMIL 20 mg | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| AUROPRAM 20 Film coated tablets | 🇹🇿Tanzania | Aurobindo Pharma Limited | active | — |
| Lopram Tablets | 🇹🇿Tanzania | Ind-Swift Laboratories Limited | active | — |
| Lopram Tablets | 🇹🇿Tanzania | Ind-Swift Laboratories Limited | active | — |
| AUROPRAM 40 Film Coated Tablet | 🇹🇿Tanzania | Aurobindo Pharma Limited | active | — |
CITALOPRAM in Africa — Regulatory Overview
CITALOPRAM is registered across 4 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, South Africa, Ghana, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.